Ethical challenges in paediatric clinical trials in multiple sclerosis
about
Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditionsOutcome measures in relapsing-remitting multiple sclerosis: capturing disability and disease progression in clinical trials.Calcium-phosphate metabolism in patients with multiple sclerosis.Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.Ethics review of pediatric multi-center drug trials.Ethical Considerations of Patient-Funded Research for Multiple Sclerosis Therapeutics.
P2860
Ethical challenges in paediatric clinical trials in multiple sclerosis
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Ethical challenges in paediatric clinical trials in multiple sclerosis
@ast
Ethical challenges in paediatric clinical trials in multiple sclerosis
@en
type
label
Ethical challenges in paediatric clinical trials in multiple sclerosis
@ast
Ethical challenges in paediatric clinical trials in multiple sclerosis
@en
prefLabel
Ethical challenges in paediatric clinical trials in multiple sclerosis
@ast
Ethical challenges in paediatric clinical trials in multiple sclerosis
@en
P2860
P356
P1476
Ethical challenges in paediatric clinical trials in multiple sclerosis
@en
P2093
Silvia N Tenembaum
P2860
P304
P356
10.1177/1756285612437360
P577
2012-05-01T00:00:00Z